Abeona Therapeutics EPS - Earnings per Share 2010-2022 | ABEO

Abeona Therapeutics eps - earnings per share from 2010 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Abeona Therapeutics Annual EPS
2021 $-21.50
2020 $-22.75
2019 $-37.75
2018 $-29.75
2017 $-16.50
2016 $-16.00
2015 $-13.25
2014 $-381.50
2013 $76.00
2012 $-650.00
2011 $-275.00
2010 $-750.00
2009 $-2,037.50
Abeona Therapeutics Quarterly EPS
2022-09-30 $-1.48
2022-06-30 $-2.08
2022-03-31 $-3.50
2021-12-31 $-11.52
2021-09-30 $-1.80
2021-06-30 $-3.93
2021-03-31 $-4.25
2020-12-31 $-4.25
2020-09-30 $-2.00
2020-06-30 $-3.50
2020-03-31 $-13.00
2019-12-31 $-7.00
2019-09-30 $-8.75
2019-06-30 $-12.25
2019-03-31 $-9.75
2018-12-31 $-9.25
2018-09-30 $-8.50
2018-06-30 $-6.50
2018-03-31 $-5.50
2017-12-31 $-4.75
2017-09-30 $-3.25
2017-06-30 $-5.25
2017-03-31 $-3.25
2016-12-31 $-4.75
2016-09-30 $-2.00
2016-06-30 $-5.00
2016-03-31 $-4.25
2015-12-31 $-2.00
2015-09-30 $-4.75
2015-06-30 $-4.00
2015-03-31 $-2.50
2014-12-31 $430.25
2014-09-30 $-103.75
2014-06-30 $-631.50
2014-03-31 $-76.50
2013-12-31 $-79.75
2013-09-30 $-44.25
2013-06-30 $37.50
2013-03-31 $162.50
2012-12-31 $987.50
2012-09-30 $-787.50
2012-06-30 $-575.00
2012-03-31 $-275.00
2011-12-31 $-12.50
2011-09-30 $0.00
2011-06-30 $-112.50
2011-03-31 $-150.00
2010-12-31 $150.00
2010-09-30 $-1,037.50
2010-06-30 $87.50
2010-03-31 $50.00
2009-12-31 $-975.00
2009-09-30 $-462.50
2009-06-30 $-300.00
2009-03-31 $-300.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.047B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00